Abstract: The present specification relates to a heterocyclic compound represented by Chemical Formula 1, and an organic light emitting device including the same.

Abstract: Disclosed is a separator including a flame retardant layer between a porous substrate and a coating layer. The coating layer includes an inorganic material on at least one surface of the porous substrate. A flame retardant layer is disposed between the porous substrate and the coating layer, whereby it is possible to obtain a rapid and accurate flame retardation effect.

Abstract: Disclosed is a method for manufacturing a separator including a heat resistant layer containing a ceramic material. The ceramic material is derived from a ceramic precursor. The method for manufacturing a separator has high convenience of processing, since the ceramic precursor can be converted into an inorganic material at a temperature lower than the melting point of the binder. In addition, the separator obtained by the method includes a heat resistant layer in which inorganic particles are not localized, locally distributed or agglomerated, and the ceramic material converted from the ceramic precursor is distributed homogeneously throughout the whole heat resistant layer. Further, there is no limitation in thickness of the heat resistant layer resulting from the particle size of the inorganic particles, and thus it is possible to form the heat resistant layer in the form of a thin film with ease.

Abstract: Provided are a compound represented by Formula 24, an organic electric element comprising a first electrode, a second electrode, and an organic material layer formed between the first electrode and the second electrode and comprising the compound of Formula 24, and an electronic device thereof, the element and device having improved driving voltage, luminous efficiency and life time from the employment of the compound.

Abstract: The present disclosure relates to a microorganism of the genus Corynebacterium producing a purine nucleotide and a method for producing a purine nucleotide using the same.

Abstract: The present invention relates to compositions containing a pterosin compound and derivatives thereof as active ingredients for the prevention or treatment of degenerative brain diseases and, more specifically, to a pharmaceutical composition for the prevention or treatment of degenerative brain diseases and a food composition for the prevention or alleviation of degenerative brain diseases, each of which contains a pterosin compound defined by chemical formula 1 or a derivative thereof as an active ingredient. A method of the present invention can be favorably used to provide a therapeutic agent for preventing or treating degenerative brain diseases, a food for alleviating degenerative brain diseases, or a functional food for the promotion of cognitive functions, by using a pterosin compound extracted from Pteridium aquilinum and derivatives thereof.

Abstract: According to the present disclosure, there is disclosed a method of processing item sales information in an electronic apparatus, the method including receiving a selection input of a user for one or more items, providing first benefit information related to the one or more items, and providing a page related to subscription of a specific membership in response to reception of an input related to the first benefit information based on account information of the user not corresponding to the specific membership, in which the first benefit information includes first discount information that is provided based on the account information of the user corresponding to the specific membership.

Abstract: A display device and a method of fabricating the display device are provided. The display device includes a display panel comprising a surface where images are displayed, and an opposite surface, and a polymer film layer disposed on the opposite surface of the display panel, wherein the polymer film layer comprises grooves recessed toward the display panel.

Abstract: Disclosed are a method for manufacturing a separator and a separator obtained thereby. The method includes forming a porous coating layer by using slurry for forming a porous coating layer including inorganic particles, lithium halide and a polyvinylidene fluoride-based binder polymer. It is possible to provide a separator showing reduced resistance and an electrochemical device including the same by modifying the properties of the binder polymer.

Abstract: The present application discloses a method for detecting an abnormity in an optical path or measuring and adjusting of a dynamic balance of a gantry in a CT system, comprising performing, by a gantry controlled by a controller, a test scan along an optical path of the CT system, the optical path being a path along which rays pass from a ray source to a detector. The method further comprises obtaining, by a processor, data relating to the test scan, and based on the data relating to the test scan. The method further comprises determining, by the processor, a status characteristic index of the optical path or an amount of dynamic imbalance of the gantry. The method further comprises analyzing, by the processor, a result of the status characteristic index; determining, by the processor, whether the optical path is abnormal, or determining whether a dynamic balance of the gantry satisfies a requirement based on a result of the analysis of the amount of dynamic imbalance.

Abstract: A Mura compensation data generation apparatus for compensating for Mura, and a Mura compensation apparatus of a display using Mura compensation data. The Mura compensation data generation apparatus includes an image representative value generation circuit configured to generate a representative value representing an entire gray of an image; a difference value extraction circuit configured to extract difference values between the representative value and gray values for a plurality of preset positions on the image; a distribution range determination circuit configured to determine a distribution range of the difference values by checking a maximum value and a minimum value of the difference values; and a Mura compensation data generation circuit configured to generate Mura compensation data having a preset number of bits corresponding to the difference values.

Abstract: A flame retardant separator for secondary batteries having an asymmetric structure, and more particularly, a flame retardant separator for secondary batteries having an asymmetric structure in which a hydroxide-based inorganic flame retardant is coated on only a surface facing a positive electrode. The present invention provides a separator, which is capable of preventing the risk of lithium ions predominantly precipitated from a negative electrode in a lithium secondary battery, enhancing the flame retardant effect, and maintaining electrochemical properties in contrast with a conventional separator coated with inorganic matters, and a lithium secondary battery including the same.

Abstract: A separator and an electrochemical device including the same. The separator includes: a porous substrate having a plurality of pores; and a first porous coating layer and a second porous coating layer formed on one surface and the other surface of the porous substrate, respectively, and including a plurality of inorganic particles, a binder polymer disposed on a part or the whole of the surface of the inorganic particles so that the inorganic particles are connected and fixed with each other, and an anionic surfactant, wherein the inorganic particles include boehmite particles and non-boehmite particles, and the boehmite particles and the binder polymer are present at a weight ratio of 1:1-1:5.

Abstract: The present invention relates to metal halide colloidal nanoparticles represented by a following Chemical Formula 1 and a method for producing the same: A3MX6??[Chemical Formula 1] wherein in the Chemical Formula 1, A is an alkali metal element, M is a rare-earth metal element, and X is a halogen element.

Abstract: The present invention relates to a composition comprising a CYP4A-inhibiting compound as an active ingredient for preventing or treating metabolic diseases, more specifically to a composition comprising the compound expressed by chemical formula 1 of the present invention or pharmaceutically acceptable salt thereof as an active ingredient for preventing, ameliorating or treating metabolic diseases.

Abstract: A storage device includes a nonvolatile memory device including a plurality of nonvolatile memories; a controller configured to allocate write blocks of the nonvolatile memory device to a plurality of streams provided from an outside; and a buffer memory configured to store a result of allocation of the write blocks to the plurality of streams, wherein the controller is further configured to reallocate the write blocks of the nonvolatile memory device to the plurality of streams based on the result of allocation stored in the buffer memory.

Abstract: The present disclosure relates to a novel protein variant having an activity of exporting 5?-inosine monophosphate, a microorganism comprising the protein variant, and a method for preparing 5?-inosine monophosphate using the microorganism.

Abstract: A method for isolating a lithium precursor according to an embodiment of the present disclosure includes preparing a preliminary precursor mixture including a preliminary lithium precursor and a preliminary transition metal precursor, mixing the preliminary precursor mixture and a precipitation liquid in a reactor to form a precursor mixture, and injecting a non-reactive gas into the precursor mixture. Accordingly, the lithium precursor can be isolated with high yield and high efficiency.

Abstract: The present invention relates to a pharmaceutical composition for the treatment of sepsis or systemic inflammatory response syndrome (SIRS) comprising mitochondria as effective ingredient. When activated macrophages and monocytes are treated with mitochondria which are effective ingredient of the pharmaceutical composition of the present invention, expression of IL-1?, TNF-? and IL-6 which are pro-inflammatory cytokines can be restored to normal levels. Furthermore, when the pharmaceutical composition of the present invention is administered to a subject suffering from sepsis, the survival rate of the subject can be remarkably increased. Therefore, the pharmaceutical composition according to the present invention can be useful for the treatment of sepsis.